Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Targeting inflammation to fight cancer is a new approach with a long history.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

How much do you know about eyes? Learn more about the fastest muscle in the human body.